Excellio Labs

Redefining the landscape of precision medicine with tissue specific exosomes

  • Biotech
Therapeutics

Member

Active

Status

2023

Founded

Development stage

  • EngBio1
    Accelerate

Excellio is pioneering breakthroughs in targeted drug delivery using the extracellular vesicles, exosomes. Its innovative technology enables advanced biological therapeutics to reach previously unaddressed targets by equipping exosomes with tissue-specific GPS systems. This approach aims to redefine the landscape of precision medicine, improving treatment efficacy and safety by optimising cargo delivery and enhancing clinical performance.

Founding team

Key contacts